Hardy Diagnostics hires research and development manager
Will accelerate entry into new molecular markets
Crowe will lead the company’s r&d and team in developing products for the diagnostic laboratory. He was recently involved in launching a product line for the molecular biology market known as CulGenex.
In addition, Crowe is expanding Hardy Diagnostics’ line of chromogenic media, which detect bacteria quickly and easily due to a colour change produced by the organisms after coming into contact with the culture media.
Jay Hardy, president of Hardy Diagnostics, said Crowe’s knowledge of molecular biology techniques would accelerate the firm’s entry into new markets.
You may also like
Cleaning
Bausch+Lomb has chosen Steriline to improve the production of sterile ophthalmic medical devices
Because Steriline’s line is compliant with the recommendations of the latest version of Annex 1, Bausch+Lomb can expand its production capacity while simultaneously minimising the risks of microbial, particulate and endotoxin/pyrogen contamination in its eye care products
Cleaning
UK wet wipe ban starting 2027: Cleanroom and medical wipes exempt under professional-use rules
Kay Goddard of Antistat & Integrity Cleanroom explains why plastic-containing wipes used in controlled environments will fall outside the consumer ban, and what businesses must do to remain compliant
Containment
Guardtech, STERIS, Kemtile and more: Experts to deliver latest research and insights - plus save £50 with early bird tickets until 23 March
The #1 conference is back with this year’s edition shaping up to be the most consequential yet with deeper technical insight, sharper conversations and a renewed focus on the challenges shaping the future of controlled environments